{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:15:00Z","timestamp":1793661300162,"version":"4.5.1"},"reference-count":126,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ijantimicag.2023.106846","type":"journal-article","created":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T06:10:08Z","timestamp":1683958208000},"page":"106846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["The battle against fungi: lessons in antifungal stewardship from COVID 19 times"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6413-3396","authenticated-orcid":false,"given":"Souha S.","family":"Kanj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7262-028X","authenticated-orcid":false,"given":"Sara F.","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques F.","family":"Meis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8600-9860","authenticated-orcid":false,"given":"Paul E.","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0689-3773","authenticated-orcid":false,"given":"Andreas","family":"Voss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riina","family":"Rautemaa-Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Levy-Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Chowdhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Ghafur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7618-725X","authenticated-orcid":false,"given":"Roger","family":"Br\u00fcggemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit M.","family":"Bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9118-4420","authenticated-orcid":false,"given":"Jeroen","family":"Schouten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2023.106846_bib0001","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1093\/cid\/ciaa524","article-title":"Coronavirus Disease 2019, Superinfections, and antimicrobial development: what can we expect?","volume":"71","author":"Clancy","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0002","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13613-021-00812-w","article-title":"Increased susceptibility to intensive care unit-acquired pneumonia in severe COVID-19 patients: a multicentre retrospective cohort study","volume":"11","author":"Llitjos","year":"2021","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0003","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.00163-21","article-title":"Coinfections with other respiratory pathogens among patients with COVID-19","volume":"9","author":"Sreenath","year":"2021","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0004","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s11046-020-00462-9","article-title":"Fungal co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China","volume":"185","author":"Song","year":"2020","journal-title":"Mycopathologia"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0005","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1016\/S2666-5247(21)00237-8","article-title":"The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries","volume":"3","author":"Hoenigl","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0006","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.01138-21","article-title":"COVID-19-associated pulmonary aspergillosis, fungemia, and pneumocystosis in the intensive care unit: a retrospective multicenter observational cohort during the first French Pandemic Wave","volume":"9","author":"Bretagne","year":"2021","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0007","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/S2666-5247(22)00261-0","article-title":"The current state of laboratory mycology and access to antifungal treatment in Europe: a European Confederation of Medical Mycology survey","volume":"4","author":"Salmanton-Garcia","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106718","article-title":"The current state of laboratory mycology in Asia\/Pacific: A survey from the European Confederation of Medical Mycology (ECMM) and International Society for Human and Animal Mycology (ISHAM)","volume":"61","author":"Salmanton-Garcia","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0009","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00134-021-06510-2","article-title":"COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges","volume":"47","author":"Prattes","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0010","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1164\/rccm.202009-3400OC","article-title":"Occurrence of invasive pulmonary fungal infections in patients with severe COVID-19 admitted to the ICU","volume":"203","author":"Fekkar","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0011","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/jamaoncol.2016.4858","article-title":"Association of risk factors, mortality, and care costs of adults with acute myeloid leukemia with admission to the intensive care unit","volume":"3","author":"Halpern","year":"2017","journal-title":"JAMA Oncol"},{"issue":"Suppl 2","key":"10.1016\/j.ijantimicag.2023.106846_bib0012","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/myc.12329","article-title":"Antifungal stewardship in daily practice and health economic implications","volume":"58","author":"Munoz","year":"2015","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0013","first-page":"2459","article-title":"Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing","volume":"71","author":"Rawson","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0014","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/jac\/dku053","article-title":"Evaluation of antifungal use in a tertiary care institution: antifungal stewardship urgently needed","volume":"69","author":"Valerio","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0015","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/jof6030138","article-title":"The quiet and underappreciated rise of drug-resistant invasive fungal pathogens","volume":"6","author":"Arastehfar","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106324","article-title":"Increased antimicrobial resistance during the COVID-19 pandemic","volume":"57","author":"Lai","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0017","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.3201\/eid2611.203504","article-title":"Multidrug-resistant Candida auris infections in critically ill coronavirus disease patients, India, April-July 2020","volume":"26","author":"Chowdhary","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0018","first-page":"615","article-title":"Candida bloodstream infection, a dire complication in hospitalized COVID-19 patients: three cases from a single center in Northern Israel","volume":"23","author":"Brikman","year":"2021","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0019","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/jof6030163","article-title":"Pan-echinocandin-resistant Candida glabrata bloodstream infection complicating COVID-19: a fatal case report","volume":"6","author":"Posteraro","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mmcr.2020.06.005","article-title":"Multi-triazole-resistant Aspergillus fumigatus and SARS-CoV-2 co-infection: A lethal combination","volume":"31","author":"Mohamed","year":"2021","journal-title":"Med Mycol Case Rep"},{"issue":"Suppl 3","key":"10.1016\/j.ijantimicag.2023.106846_bib0021","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1093\/infdis\/jiaa394","article-title":"Core recommendations for antifungal stewardship: a statement of the Mycoses Study Group Education and Research Consortium","volume":"222","author":"Johnson","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0022","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00134-021-06449-4","article-title":"Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis","volume":"47","author":"Verweij","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0023","doi-asserted-by":"crossref","first-page":"e1634","DOI":"10.1093\/cid\/ciaa1298","article-title":"A national strategy to diagnose coronavirus disease 2019-associated invasive fungal disease in the intensive care unit","volume":"73","author":"White","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"Suppl 7","key":"10.1016\/j.ijantimicag.2023.106846_bib0024","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0025","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0026","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S2213-2600(21)00442-2","article-title":"Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study","volume":"10","author":"Gangneux","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0027","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03142-2021","article-title":"Aspergillus tracheobronchitis in COVID-19 patients with acute respiratory distress syndrome: a cohort study","volume":"59","author":"Koehler","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0028","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0029","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01229-21","article-title":"Aspergillus test profiles and mortality in critically ill COVID-19 patients","volume":"59","author":"Ergun","year":"2021","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0030","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.21037\/apm-21-2043","article-title":"Incidence and outcomes of patients with COVID-19 associated pulmonary aspergillosis (CAPA) in intensive care units: a systematic review and meta-analysis of 31 cohort studies","volume":"11","author":"Chen","year":"2022","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0031","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/cid\/ciab562","article-title":"The landscape of candidemia during the coronavirus disease 2019 (COVID-19) pandemic","volume":"74","author":"Seagle","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0032","doi-asserted-by":"crossref","first-page":"ofab566","DOI":"10.1093\/ofid\/ofab566","article-title":"Coronavirus disease 2019-associated mucormycosis in France: a rare but deadly complication","volume":"9","author":"Danion","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0033","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S2213-2600(21)00138-7","article-title":"COVID-19-associated Aspergillus tracheobronchitis: the interplay between viral tropism, host defence, and fungal invasion","volume":"9","author":"van de Veerdonk","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0034","doi-asserted-by":"crossref","first-page":"e3606","DOI":"10.1093\/cid\/ciaa1065","article-title":"Epidemiology of invasive pulmonary aspergillosis among intubated patients with COVID-19: a prospective study","volume":"73","author":"Bartoletti","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0035","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.02169-21","article-title":"Combination of mycological criteria: a better surrogate to identify COVID-19-associated pulmonary aspergillosis patients and evaluate prognosis?","volume":"60","author":"Delliere","year":"2022","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0036","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01689-21","article-title":"Aspergillus lateral flow assay with digital reader for the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA): a Multicenter Study","volume":"60","author":"Autier","year":"2022","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0037","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0038","first-page":"173","article-title":"Epidemiology, diagnosis and treatment of fungal respiratory infections in the critically ill patient","volume":"26","author":"Garnacho-Montero","year":"2013","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0039","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/myc.13379","article-title":"Results from a national survey on COVID-19-associated mucormycosis in Germany: 13 patients from six tertiary hospitals","volume":"65","author":"Seidel","year":"2022","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271795","article-title":"Antifungal therapy in the management of fungal secondary infections in COVID-19 patients: A systematic review and meta-analysis","volume":"17","author":"Sah","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0041","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0042","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/myc.13335","article-title":"ECMM\/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries","volume":"64","author":"Rudramurthy","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0043","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0044","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1128\/JCM.01915-07","article-title":"Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005","volume":"46","author":"Pfaller","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2014.12.027","article-title":"Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: results from a population-based surveillance in Spain","volume":"21","author":"Puig-Asensio","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0046","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/pathogens10020157","article-title":"First Candida auris outbreak during a COVID-19 pandemic in a tertiary-care center in Lebanon","volume":"10","author":"Allaw","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0047","doi-asserted-by":"crossref","first-page":"ofab452","DOI":"10.1093\/ofid\/ofab452","article-title":"A high frequency of Candida auris blood stream infections in coronavirus disease 2019 patients admitted to intensive care units, Northwestern India: a case control study","volume":"8","author":"Rajni","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0048","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cmi.2018.11.027","article-title":"Triazole resistance in Aspergillus fumigatus: recent insights and challenges for patient management","volume":"25","author":"Lestrade","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0049","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/myc.13096","article-title":"COVID-19 associated pulmonary aspergillosis","volume":"63","author":"Koehler","year":"2020","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/myc.13183","article-title":"Bronchoscopy safety precautions for diagnosing COVID-19 associated pulmonary aspergillosis-A simulation study","volume":"64","author":"Koehler","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106409","article-title":"Antimicrobial stewardship in the ICU in COVID-19 times: the known unknowns","volume":"58","author":"Schouten","year":"2021","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl 1","key":"10.1016\/j.ijantimicag.2023.106846_bib0052","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 7","key":"10.1016\/j.ijantimicag.2023.106846_bib0053","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/imj.15585","article-title":"Introduction to the updated Australasian consensus guidelines for the management of invasive fungal disease and use of antifungal agents in the haematology\/oncology setting, 2021","volume":"51","author":"Chang","year":"2021","journal-title":"Intern Med J"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0054","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s13054-021-03753-9","article-title":"Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: An observational study","volume":"25","author":"Hatzl","year":"2021","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0055","doi-asserted-by":"crossref","first-page":"e0696","DOI":"10.1097\/CCE.0000000000000696","article-title":"Nebulized amphotericin B in mechanically ventilated COVID-19 patients to prevent invasive pulmonary aspergillosis: a retrospective cohort study","volume":"4","author":"Melchers","year":"2022","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0056","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s13054-021-03728-w","article-title":"Inhaled liposomal amphotericin-B as a prophylactic treatment for COVID-19-associated pulmonary aspergillosis\/aspergillus tracheobronchitis","volume":"25","author":"Van Ackerbroeck","year":"2021","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0057","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/jcpt.13518","article-title":"Suboptimal plasma concentrations with posaconazole suspension as prophylaxis in critically ill COVID-19 patients at risk of Covid-associated pulmonary aspergillosis","volume":"47","author":"Mian","year":"2022","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0058","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13613-020-00686-4","article-title":"COVID-19-associated invasive pulmonary aspergillosis","volume":"10","author":"Rutsaert","year":"2020","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0059","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00134-021-06603-y","article-title":"Inhaled amphotericin B lipid complex for prophylaxis against COVID-19-associated invasive pulmonary aspergillosis","volume":"48","author":"Soriano","year":"2022","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0060","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.1016\/S1473-3099(20)30784-2","volume":"21","author":"Hoenigl","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0061","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3390\/antibiotics11050645","article-title":"Therapeutic Drug Monitoring of Antifungal Agents in Critically Ill Patients: Is There a Need for Dose Optimisation?","volume":"11","author":"Baracaldo-Santamaria","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0062","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/myc.13446","article-title":"Exposure to intravenous posaconazole in critically ill patients with influenza: A pharmacokinetic analysis of the POSA-FLU study","volume":"65","author":"Van Daele","year":"2022","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0063","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01398-17","article-title":"Pharmacokinetic properties of micafungin in critically ill patients diagnosed with invasive candidiasis","volume":"61","author":"Boonstra","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0064","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s40262-016-0495-z","article-title":"Caspofungin population pharmacokinetics in critically ill patients undergoing continuous veno-venous haemofiltration or haemodiafiltration","volume":"56","author":"Roger","year":"2017","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0065","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s15010-017-1042-z","article-title":"Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients","volume":"45","author":"Bellmann","year":"2017","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0066","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/jac\/dkt508","article-title":"Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology","volume":"69","author":"Ashbee","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 2","key":"10.1016\/j.ijantimicag.2023.106846_bib0067","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1093\/mmy\/myy052","article-title":"Broad spectrum triazoles for invasive mould infections in adults: Which drug and when?","volume":"57","author":"Jenks","year":"2019","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0068","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/clpt.2010.64","article-title":"Exposure-response of posaconazole used for prophylaxis against invasive fungal infections: evaluating the need to adjust doses based on drug concentrations in plasma","volume":"88","author":"Jang","year":"2010","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl 7","key":"10.1016\/j.ijantimicag.2023.106846_bib0069","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/imj.15591","article-title":"Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021","volume":"51","author":"Douglas","year":"2021","journal-title":"Intern Med J"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0070","first-page":"71","article-title":"Invasive fungal infections in patients with COVID-19: a review on pathogenesis, epidemiology, clinical features, treatment, and outcomes","volume":"44","author":"Chiurlo","year":"2021","journal-title":"New Microbiol"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0071","doi-asserted-by":"crossref","first-page":"18026","DOI":"10.1038\/nrdp.2018.26","article-title":"Invasive candidiasis","volume":"4","author":"Pappas","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"Suppl 1","key":"10.1016\/j.ijantimicag.2023.106846_bib0072","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1093\/cid\/cir885","article-title":"Combination therapy for mucormycosis: why, what, and how?","volume":"54","author":"Spellberg","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0073","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.3390\/jcm11133620","article-title":"Current treatment options for COVID-19 associated mucormycosis: present status and future perspectives","volume":"11","author":"Madhavan","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0074","doi-asserted-by":"crossref","first-page":"56","DOI":"10.15585\/mmwr.mm7002e3","article-title":"Candida auris Outbreak in a COVID-19 Specialty Care Unit - Florida, July-August 2020","volume":"70","author":"Prestel","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0075","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/myc.12699","article-title":"In vitro efficacy of disinfectants utilised for skin decolonisation and environmental decontamination during a hospital outbreak with Candida auris","volume":"60","author":"Abdolrasouli","year":"2017","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0076","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3389\/fmicb.2018.00726","article-title":"Candida auris: disinfectants and implications for infection control","volume":"9","author":"Ku","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0077","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3390\/jof6040286","article-title":"Is the frequency of candidemia increasing in COVID-19 patients receiving corticosteroids?","volume":"6","author":"Riche","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0078","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/myc.13258","article-title":"Epidemiology and mycology of Candidaemia in non-oncological medical intensive care unit patients in a tertiary center in the United States: Overall analysis and comparison between non-COVID-19 and COVID-19 cases","volume":"64","author":"Macauley","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0079","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/mmy\/myab056","article-title":"Clinical characteristics and risk factors for COVID-19-associated Candidemia","volume":"59","author":"Omrani","year":"2021","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0080","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3390\/microorganisms10051011","article-title":"COVID-19 and C. auris: a case-control study from a tertiary care center in Lebanon","volume":"10","author":"Allaw","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0081","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00284-022-02824-6","article-title":"COVID-19-associated candidiasis: possible patho-mechanism, predisposing factors, and prevention strategies","volume":"79","author":"Ahmed","year":"2022","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0082","doi-asserted-by":"crossref","DOI":"10.1136\/bmjoq-2020-001200","article-title":"Bundle approach used to achieve zero central line-associated bloodstream infections in an adult coronary intensive care unit","volume":"10","author":"Gupta","year":"2021","journal-title":"BMJ Open Qual"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0083","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/21548331.2018.1510282","article-title":"Infection control measures to prevent hospital transmission of Candida","volume":"46","author":"Ture","year":"2018","journal-title":"Hosp Pract (1995)"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0084","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s10096-013-2027-1","article-title":"Multidrug-resistant endemic clonal strain of Candida auris in India","volume":"33","author":"Chowdhary","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0085","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijantimicag.2019.08.013","article-title":"Control of Candida auris in healthcare institutions: Outcome of an International Society for Antimicrobial Chemotherapy expert meeting","volume":"54","author":"Kenters","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0086","unstructured":"Centers for Diseases Control and Prevention. Infection Prevention and Control for Candida auris. Available at: Candida auris | Candida auris | Fungal Diseases | CDC. (Last accessed 30\/03\/23)"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0087","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jhin.2021.11.004","article-title":"Colonization by Candida auris in critically ill patients: role of cutaneous and rectal localization during an outbreak","volume":"120","author":"Piatti","year":"2022","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0088","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3390\/jof6040224","article-title":"Candida auris direct detection from surveillance swabs, blood, and urine using a laboratory-developed PCR method","volume":"6","author":"Walchak","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2020.12.002","article-title":"Murine model of colonization with fungal pathogen Candida auris to explore skin tropism, host risk factors and therapeutic strategies","volume":"29","author":"Huang","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0090","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1017\/ice.2019.1","article-title":"Susceptibility of Candida auris and Candida albicans to 21 germicides used in healthcare facilities","volume":"40","author":"Rutala","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0091","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3390\/jof7100804","article-title":"Augmenting the activity of chlorhexidine for decolonization of Candida auris from porcine skin","volume":"7","author":"Johnson","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0092","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ijantimicag.2018.05.007","article-title":"The comparative efficacy of antiseptics against Candida auris biofilms","volume":"52","author":"Kean","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0093","unstructured":"Public Heath England. Candida auris: laboratory investigation, management and infection prevention and control. Available at: extension:\/\/elhekieabhbkpmcefcoobjddigjcaadp\/https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/637685\/Updated_Candida_auris_Guidance_v2.pdf (Last accessed 30\/03\/23)"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0094","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/myc.12903","article-title":"Killing of Candida auris by UV-C: Importance of exposure time and distance","volume":"62","author":"de Groot","year":"2019","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0095","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/ina.12531","article-title":"Effects of indoor environmental parameters related to building heating, ventilation, and air conditioning systems on patients' medical outcomes: A review of scientific research on hospital buildings","volume":"29","author":"Shajahan","year":"2019","journal-title":"Indoor Air"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0096","unstructured":"Centers for Diseases Control and Prevention. Isolation and precautions for people with COVID-19. Available at: Infection Prevention and Control for Candida auris | Candida auris | Fungal Diseases | CDC. (Last accessed: 30\/03\/23)"},{"issue":"Suppl 19","key":"10.1016\/j.ijantimicag.2023.106846_bib0097","doi-asserted-by":"crossref","first-page":"S2295","DOI":"10.21037\/jtd.2018.01.24","article-title":"Ventilation control for airborne transmission of human exhaled bio-aerosols in buildings","volume":"10","author":"Qian","year":"2018","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0098","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jhin.2003.10.011","article-title":"Positive-pressure isolation and the prevention of invasive aspergillosis. What is the evidence?","volume":"56","author":"Humphreys","year":"2004","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0099","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1186\/s13054-020-03221-w","article-title":"Impact of negative air pressure in ICU rooms on the risk of pulmonary aspergillosis in COVID-19 patients","volume":"24","author":"Ichai","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0100","doi-asserted-by":"crossref","first-page":"972","DOI":"10.15585\/mmwr.mm7027e1","article-title":"Efficacy of portable air cleaners and masking for reducing indoor exposure to simulated exhaled SARS-CoV-2 aerosols - United States, 2021","volume":"70","author":"Lindsley","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0101","doi-asserted-by":"crossref","first-page":"770","DOI":"10.15585\/mmwr.mm7123e2","article-title":"Ventilation improvement strategies among K-12 public schools - The National School COVID-19 Prevention Study, United States, February 14-March 27, 2022","volume":"71","author":"Pampati","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0102","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/mmy\/myz031","article-title":"An aero mycological analysis of Mucormycetes in indoor and outdoor environments of northern India","volume":"58","author":"Prakash","year":"2020","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0103","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.953750","article-title":"Evaluation of environmental Mucorales contamination in and around the residence of COVID-19-associated mucormycosis patients","volume":"12","author":"Ghosh","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0104","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jhin.2022.01.016","article-title":"Evaluation of hospital environment for presence of Mucorales during COVID-19-associated mucormycosis outbreak in India - a multi-centre study","volume":"122","author":"Biswal","year":"2022","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12281-022-00434-0","article-title":"Overview of COVID-19-associated invasive fungal infection","volume":"16","author":"Shishido","year":"2022","journal-title":"Curr Fungal Infect Rep"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0106","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jinf.2021.12.039","article-title":"Risk factors for Coronavirus disease-associated mucormycosis","volume":"84","author":"Arora","year":"2022","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0107","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0108","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1099\/jmm.0.000612","article-title":"An investigation of antifungal stewardship programmes in England","volume":"66","author":"Micallef","year":"2017","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0109","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12941-019-0323-z","article-title":"A systematic review of the impact of antifungal stewardship interventions in the United States","volume":"18","author":"Hart","year":"2019","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0110","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/QCO.0b013e32834e0680","article-title":"The case for antifungal stewardship","volume":"25","author":"Ananda-Rajah","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0111","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/jac\/dkaa409","article-title":"Establishing essential metrics for antifungal stewardship in hospitals: the results of an international Delphi survey","volume":"76","author":"Khanina","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0112","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s10096-018-3335-2","article-title":"Repeated antifungal use audits are essential for selecting the targets for intervention in antifungal stewardship","volume":"37","author":"Valerio","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0113","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/jac\/dkx388","article-title":"A systematic review of interventions and performance measures for antifungal stewardship programmes","volume":"73","author":"Bienvenu","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0114","doi-asserted-by":"crossref","first-page":"e28906","DOI":"10.1097\/MD.0000000000028906","article-title":"A quality improvement initiative to improve the appropriateness of candidemia management by the implementation of a comprehensive candidemia care bundle at a tertiary care hospital in South India: Results of a quasi-experimental study","volume":"101","author":"Moni","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106255","article-title":"Impact of a non-compulsory antifungal stewardship program on overuse and misuse of antifungal agents in a tertiary care hospital","volume":"57","author":"Markogiannakis","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0116","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/jof8010018","article-title":"Precision therapy for invasive fungal diseases","volume":"8","author":"Martson","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0117","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/myc.13404","article-title":"Collateral consequences of agricultural fungicides on pathogenic yeasts: A One Health perspective to tackle azole resistance","volume":"65","author":"Castelo-Branco","year":"2022","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0118","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41579-022-00720-1","article-title":"Tackling the emerging threat of antifungal resistance to human health","volume":"20","author":"Fisher","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0119","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2021.26.8.1900730","article-title":"Screening for Candida auris in patients admitted to eight intensive care units in England, 2017 to 2018","volume":"26","author":"Sharp","year":"2021","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0120","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/myc.13533","article-title":"Usefulness of screening for Candida auris colonisation in international patients admitted to a large university hospital","volume":"66","author":"Heindel","year":"2023","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0121","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1080\/21505594.2016.1226721","article-title":"Antifungal stewardship considerations for adults and pediatrics","volume":"8","author":"Hamdy","year":"2017","journal-title":"Virulence"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0122","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/jac\/dky389","article-title":"Effectiveness of an antifungal stewardship programme at a London teaching hospital 2010-16","volume":"74","author":"Whitney","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0123","doi-asserted-by":"crossref","first-page":"ofab510","DOI":"10.1093\/ofid\/ofab510","article-title":"Coronavirus disease 2019-associated invasive fungal infection","volume":"8","author":"Baddley","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0124","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(14)61861-4","article-title":"British Society of Medical Mycology. Antifungal resistance: more research needed","volume":"384","author":"Barnes","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2023.106846_bib0125","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3389\/fgene.2018.00376","article-title":"Diagnosing emerging fungal threats: A One Health perspective","volume":"9","author":"Ghosh","year":"2018","journal-title":"Front Genet"},{"issue":"6","key":"10.1016\/j.ijantimicag.2023.106846_bib0126","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/myc.13578","article-title":"Multimodal analysis of the COVID-19-associated mucormycosis outbreak in Delhi, India indicates the convergence of clinical and environmental risk factors","volume":"66","author":"Chowdhary","year":"2023","journal-title":"Mycoses"}],"updated-by":[{"DOI":"10.1016\/j.ijantimicag.2023.106901","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000}}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857923001255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857923001255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T12:54:09Z","timestamp":1702385649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857923001255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":126,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0924857923001255"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106846","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ijantimicag.2023.106901","asserted-by":"object"}]},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The battle against fungi: lessons in antifungal stewardship from COVID 19 times","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106846","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106846"}}